Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Smetsers

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Antisense & Nucleic Acid Drug Development|January 1, 1996
Bias in nucleotide composition of antisense oligonucleotidesT F Smetsers, J B Boezeman, E J Mensink
Leukemia|October 1, 1994
Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemiaL T van de Locht, T F Smetsers, S Wittebol, et al.
Journal of Chromatography. B, Biomedical Applications|October 14, 1994
Quantitative analysis of DNA aberrations amplified by competitive polymerase chain reaction using capillary electrophoresisA W Kuypers, J P Meijerink, T F Smetsers, et al.
Leukemia|November 1, 1995
Bax mutations in cell lines derived from hematological malignanciesJ P Meijerink, T F Smetsers, A W Slöetjes, et al.
British Journal of Haematology|June 1, 1993
Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reactionJ P Meijerink, T F Smetsers, J M Raemaekers, et al.
British Journal of Haematology|February 1, 1997
An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanismT F Smetsers, E H Linders, L T van de Locht, et al.
Leukemia|January 1, 1995
Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levelsT F Smetsers, L T van de Locht, A H Pennings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantationJ P Meijerink, G J Goverde, T F Smetsers, et al.
Leukemia|January 1, 1994
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173T F Smetsers, T Skorski, L T van de Locht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantationB M Bär, A Schattenberg, E J Mensink, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Antisense & Nucleic Acid Drug Development|January 1, 1996
Bias in nucleotide composition of antisense oligonucleotidesT F Smetsers, J B Boezeman, E J Mensink
Leukemia|October 1, 1994
Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemiaL T van de Locht, T F Smetsers, S Wittebol, et al.
Journal of Chromatography. B, Biomedical Applications|October 14, 1994
Quantitative analysis of DNA aberrations amplified by competitive polymerase chain reaction using capillary electrophoresisA W Kuypers, J P Meijerink, T F Smetsers, et al.
Leukemia|November 1, 1995
Bax mutations in cell lines derived from hematological malignanciesJ P Meijerink, T F Smetsers, A W Slöetjes, et al.
British Journal of Haematology|June 1, 1993
Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reactionJ P Meijerink, T F Smetsers, J M Raemaekers, et al.
British Journal of Haematology|February 1, 1997
An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanismT F Smetsers, E H Linders, L T van de Locht, et al.
Leukemia|January 1, 1995
Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levelsT F Smetsers, L T van de Locht, A H Pennings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantationJ P Meijerink, G J Goverde, T F Smetsers, et al.
Leukemia|January 1, 1994
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173T F Smetsers, T Skorski, L T van de Locht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantationB M Bär, A Schattenberg, E J Mensink, et al.
Pageof 1